Evolution of Systemic Treatment Uptake and Survival in Advanced Non-Small Cell Lung Cancer

Abstract

Systemic treatment rose across three time periods, reflecting the introduction of rapid diagnostic pathways, reflex molecular testing, ICI, and targeted therapies. Survival outcomes of advanced NSCLC patients have significantly improved.